Who Paid My Doc
021Fsgs16010
Research payments
$6,441,372
Through program year 2024, $6,441,372 in research payments was reported against 021Fsgs16010, across 4,604 payments, paid by Retrophin, Inc..
- Paid by
- Retrophin, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $792,868 | 676 |
| 2023 | Research | $594,108 | 473 |
| 2022 | Research | $344,931 | 282 |
| 2021 | Research | $1,587,465 | 1,174 |
| 2020 | Research | $2,216,129 | 1,512 |
| 2019 | Research | $905,871 | 487 |
Breakdown
Usually the institution or organisation running the study, not a person.
Only reported on some payments, and a payment can report more than one category, so these amounts overlap.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
7 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jonathan Hogan Philadelphia, PA Named on 163 payments
- Sreedhar Mandayam Houston, TX Named on 124 payments
- Frederick Kaskel Mamaroneck, NY Named on 121 payments
- James Tumlin Lawrenceville, GA Named on 88 payments
- Rasheed Gbadegesin Durham, NC Named on 63 payments
- Kenneth Lieberman Hackensack, NJ Named on 54 payments
- Carlos Mercado Saint George, UT Named on 54 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.